Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Johannes Törnig"'
Autor:
Jolanthe Kapitza, Christiane P. Tiefenbacher, Lars P. Kihm, Johannes Törnig, Martin Zeier, Kerstin Amann, Ralf Dikow, Eberhard Ritz
Publikováno v:
Journal of the American Society of Nephrology. 15:1530-1536
In patients with renal failure, myocardial infarction (MI) is more frequent and the rate of death from acute MI is very high. It has been argued that ischemia tolerance of the heart is reduced in uremia, but direct evidence for this hypothesis has no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7885c5f2c9e17301bcd13856eb09048
https://doi.org/10.1097/01.asn.0000130154.42061.c6
https://doi.org/10.1097/01.asn.0000130154.42061.c6
Autor:
Marie-Luise Gross, Kerstin Amann, Johannes Törnig, Eberhard Ritz, Gerhard Mall, Ute Schwarz, Christian S. Haas, Karin Tyralla
Publikováno v:
Kidney International. 63(5):1708-1713
Cardiomyocyte loss in experimental renal failure: Prevention by ramipril.BackgroundThe development of left ventricular hypertrophy (LVH) and of structural abnormalities of the heart is a key abnormality in renal failure that potentially contributes t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc46e645232730f20df366878dc0837
Publikováno v:
Journal of the American Society of Nephrology. 14:311-316
Rodents do not develop spontaneous atherosclerosis. Currently, there is no good animal model to study the effect of uremia on atherosclerosis. This study evaluated whether apolipoprotein E knockout (Apoe-/-) mice are useful to study the effect of ren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67ab9229a403e300a247b5140fe8478e
https://doi.org/10.1097/01.asn.0000045048.71975.fc
https://doi.org/10.1097/01.asn.0000045048.71975.fc
Publikováno v:
Seminars in Dialysis. 12:288-292
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1f551e239404f484a258b5176ff9db1
https://doi.org/10.1046/j.1525-139x.1999.99037.x
https://doi.org/10.1046/j.1525-139x.1999.99037.x
Autor:
Abdussalam El-Shakmak, Karin Tyralla, Johannes Törnig, Marie-Luise Gross, András Szabó, E. Ritz, Birgit Kugel, Kerstin Amann
Publikováno v:
Kidney international. 63(4)
Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.BackgroundHyperphosphatemia is a known predictor of cardiovascular death and specifically of cardiac death in hemodialysis patients. The pathomechanisms in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a26567a733e674f4d21da2135a9f3b
https://pubmed.ncbi.nlm.nih.gov/12631346
https://pubmed.ncbi.nlm.nih.gov/12631346